Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 5,387 | 1,821 | 3,276 | 1,117 | 1,114 |
| Operating Income | -5,387 | -1,821 | -3,276 | -1,117 | -1,114 |
| Interest Expense | 12 | 755 | 2,366 | 792 | 606 |
| Other Income | -1,649 | -26,946 | -580 | 819 | -302 |
| Pre-tax Income | -7,048 | -29,522 | -6,221 | -1,090 | -2,021 |
| Income Tax | N/A | -2 | N/A | N/A | N/A |
| Net Income Continuous | -7,048 | -29,520 | -6,221 | -1,090 | -2,021 |
| Net Income | $-7,048 | $-29,524 | $-6,221 | $-1,090 | $-2,021 |
| EPS Basic Total Ops | -157.96 | -577.48 | -132.43 | -25.23 | -47.45 |
| EPS Basic Continuous Ops | -130.33 | -568.62 | -132.10 | -25.15 | -47.44 |
| EPS Diluted Total Ops | -157.96 | -577.48 | -118.02 | -32.43 | -57.06 |
| EPS Diluted Continuous Ops | -130.33 | -568.62 | -132.83 | -25.15 | -46.72 |
| EBITDA(a) | $-5,365 | $-1,261 | $-1,193 | $-608 | $-784 |